Cognitive Research Corporation

Cognitive Research Corporation (CRC) is a full-service clinical research organization focused on central nervous system (CNS) disorders, including neurology, psychiatry, and analgesia. With decades of experience and a specialized team of experts, CRC provides tailored support across Phase I–III trials, helping sponsors navigate the complex path from early development through FDA submission. CRC takes a hands-on, concierge approach to clinical trial execution—ensuring consistency, accuracy, and urgency across every program.

From site strategy and rater surveillance to medical monitoring and data management, every element is informed by deep CNS expertise and proven operational excellence. Our strength lies in collaboration: we work closely with sponsors, high-performing research sites, and key opinion leaders to ensure trials are executed with precision. Whether supporting studies in Alzheimer’s disease, schizophrenia, major depressive disorder, or novel psychedelic therapies, CRC is committed to delivering high-quality data and accelerating the development of life-changing treatments. By uniting scientific rigor with operational agility, CRC helps advance innovative assets through rigorous testing and toward regulatory success—ultimately improving outcomes for patients living with CNS disorders.